Safety and efficacy of sodium oligomannate in patients with Alzheimer’s disease: a systematic review and meta-analysis
Abstract Background We aim to evaluate the efficacy and safety of a new marine oligosaccharide drug, sodium oligomannate (GV-971), developed in China to treat Alzheimer’s disease (AD). Methods We researched the following databases: Embase, Web of Science, PubMed, Cochrane library, and Scopus until S...
I tiakina i:
| Ngā kaituhi matua: | , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
SpringerOpen
2023-06-01
|
| Rangatū: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s41983-023-00682-y |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|